Vycor Medical Statistics
Total Valuation
Vycor Medical has a market cap or net worth of 2.34 million. The enterprise value is 3.26 million.
| Market Cap | 2.34M |
| Enterprise Value | 3.26M |
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Vycor Medical has 33.42 million shares outstanding. The number of shares has increased by 1.48% in one year.
| Current Share Class | 33.42M |
| Shares Outstanding | 33.42M |
| Shares Change (YoY) | +1.48% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.15% |
| Owned by Institutions (%) | n/a |
| Float | 13.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.25 |
| PB Ratio | -0.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.19, with an EV/FCF ratio of -174.26.
| EV / Earnings | -8.21 |
| EV / Sales | 1.75 |
| EV / EBITDA | 18.19 |
| EV / EBIT | 96.10 |
| EV / FCF | -174.26 |
Financial Position
The company has a current ratio of 0.12
| Current Ratio | 0.12 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | 5.63 |
| Debt / FCF | -53.94 |
| Interest Coverage | 0.33 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 2.32% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -0.86% |
| Weighted Average Cost of Capital (WACC) | 3.84% |
| Revenue Per Employee | 266,200 |
| Profits Per Employee | -56,685 |
| Employee Count | 7 |
| Asset Turnover | 2.04 |
| Inventory Turnover | 1.98 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.94% in the last 52 weeks. The beta is -0.41, so Vycor Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.41 |
| 52-Week Price Change | +2.94% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 38.18 |
| Average Volume (20 Days) | 19,831 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.27 |
Income Statement
In the last 12 months, Vycor Medical had revenue of 1.86 million and -396,796 in losses. Loss per share was -0.01.
| Revenue | 1.86M |
| Gross Profit | 1.56M |
| Operating Income | 33,900 |
| Pretax Income | -70,190 |
| Net Income | -396,796 |
| EBITDA | 97,043 |
| EBIT | 33,900 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 86,982 in cash and 1.01 million in debt, with a net cash position of -921,421 or -0.03 per share.
| Cash & Cash Equivalents | 86,982 |
| Total Debt | 1.01M |
| Net Cash | -921,421 |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -4.09M |
| Book Value Per Share | -0.12 |
| Working Capital | -4.22M |
Cash Flow
In the last 12 months, operating cash flow was -13,471 and capital expenditures -5,224, giving a free cash flow of -18,695.
| Operating Cash Flow | -13,471 |
| Capital Expenditures | -5,224 |
| Depreciation & Amortization | 63,143 |
| Net Borrowing | -812 |
| Free Cash Flow | -18,695 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 83.78%, with operating and profit margins of 1.82% and -3.89%.
| Gross Margin | 83.78% |
| Operating Margin | 1.82% |
| Pretax Margin | -3.77% |
| Profit Margin | -3.89% |
| EBITDA Margin | 5.21% |
| EBIT Margin | 1.82% |
| FCF Margin | n/a |
Dividends & Yields
Vycor Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.48% |
| Shareholder Yield | -1.48% |
| Earnings Yield | -16.98% |
| FCF Yield | -0.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 15, 2013. It was a reverse split with a ratio of 0.0066666.
| Last Split Date | Jan 15, 2013 |
| Split Type | Reverse |
| Split Ratio | 0.0066666 |
Scores
Vycor Medical has an Altman Z-Score of -59.88 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -59.88 |
| Piotroski F-Score | 4 |